A network of excellence

Beating incurable diseases requires strong commitment from all stakeholders: research institutes, technology centers, biotechnology companies, healthcare leaders, governments, public health organizations and obviously patients. The company actively participates in this dynamic by establishing partnerships at all stages of its development process with world class leaders in their fields. Such partnerships enable Diaccurate to:

  • Capture the best of discovery and innovation in oncology and immunology
  • Strengthen its expertise in research and development
  • Access to breakthrough technologies and engineering
  • Maximize the impact of its innovations

The quality and diversity of Diaccurate’s partnerships testifies to the dynamism and attractiveness of the company.